349 related articles for article (PubMed ID: 28068099)
1. Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.
Anchordoquy TJ; Barenholz Y; Boraschi D; Chorny M; Decuzzi P; Dobrovolskaia MA; Farhangrazi ZS; Farrell D; Gabizon A; Ghandehari H; Godin B; La-Beck NM; Ljubimova J; Moghimi SM; Pagliaro L; Park JH; Peer D; Ruoslahti E; Serkova NJ; Simberg D
ACS Nano; 2017 Jan; 11(1):12-18. PubMed ID: 28068099
[TBL] [Abstract][Full Text] [Related]
2. Translational considerations in nanomedicine: The oncology perspective.
Gabizon AA; de Rosales RTM; La-Beck NM
Adv Drug Deliv Rev; 2020; 158():140-157. PubMed ID: 32526450
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions.
Anchordoquy T; Artzi N; Balyasnikova IV; Barenholz Y; La-Beck NM; Brenner JS; Chan WCW; Decuzzi P; Exner AA; Gabizon A; Godin B; Lai SK; Lammers T; Mitchell MJ; Moghimi SM; Muzykantov VR; Peer D; Nguyen J; Popovtzer R; Ricco M; Serkova NJ; Singh R; Schroeder A; Schwendeman AA; Straehla JP; Teesalu T; Tilden S; Simberg D
ACS Nano; 2024 Jun; 18(22):13983-13999. PubMed ID: 38767983
[TBL] [Abstract][Full Text] [Related]
4. Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy.
Moosavian SA; Bianconi V; Pirro M; Sahebkar A
Semin Cancer Biol; 2021 Feb; 69():337-348. PubMed ID: 31585213
[TBL] [Abstract][Full Text] [Related]
5. Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.
Babu A; Templeton AK; Munshi A; Ramesh R
AAPS PharmSciTech; 2014 Jun; 15(3):709-21. PubMed ID: 24550101
[TBL] [Abstract][Full Text] [Related]
6. The EPR effect and beyond: Strategies to improve tumor targeting and cancer nanomedicine treatment efficacy.
Shi Y; van der Meel R; Chen X; Lammers T
Theranostics; 2020; 10(17):7921-7924. PubMed ID: 32685029
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review.
Indoria S; Singh V; Hsieh MF
Int J Pharm; 2020 May; 582():119314. PubMed ID: 32283197
[TBL] [Abstract][Full Text] [Related]
8. Progress in the delivery of nanoparticle constructs: towards clinical translation.
Ryan SM; Brayden DJ
Curr Opin Pharmacol; 2014 Oct; 18():120-8. PubMed ID: 25450066
[TBL] [Abstract][Full Text] [Related]
9. Molecular-targeted nanotherapies in cancer: enabling treatment specificity.
Blanco E; Hsiao A; Ruiz-Esparza GU; Landry MG; Meric-Bernstam F; Ferrari M
Mol Oncol; 2011 Dec; 5(6):492-503. PubMed ID: 22071376
[TBL] [Abstract][Full Text] [Related]
10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
12. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine Tumor Targeting.
Lammers T
Adv Mater; 2024 Jun; 36(26):e2312169. PubMed ID: 38361435
[TBL] [Abstract][Full Text] [Related]
14. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
15. Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy.
Ganta S; Talekar M; Singh A; Coleman TP; Amiji MM
AAPS PharmSciTech; 2014 Jun; 15(3):694-708. PubMed ID: 24510526
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
17. Progress and challenges towards targeted delivery of cancer therapeutics.
Rosenblum D; Joshi N; Tao W; Karp JM; Peer D
Nat Commun; 2018 Apr; 9(1):1410. PubMed ID: 29650952
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
[TBL] [Abstract][Full Text] [Related]
19. Implications of nanotechnology for the treatment of cancer: Recent advances.
Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
[TBL] [Abstract][Full Text] [Related]
20. In Silico Models for Nanomedicine: Recent Developments.
Mascheroni P; Schrefler BA
Curr Med Chem; 2018; 25(34):4192-4207. PubMed ID: 28911299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
